Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).
Source facts
Action
Stago sent an Urgent Field Safety Notice letter dated October 25, 2017 to their customers. The letter identified the affected product, problem and actions to be taken:
Customers were instructed to:
If it is not already done, run a Quality Control test at every change of vial (if you have affected lots of product).
Return to company, by fax or email, an acknowledgement form confirming that the recall letter was read by the receiving company.
For questions contact the Stago Hotline (1-800-725-0607).
Initiated
2017-10-25
Root cause
Device Design
Terminated
2020-05-12
Distribution
Nationally
Recall number
Z-1067-2018
Recall status
Terminated
CDRH record ID
161828
FDA record created
2018-03-15
Recall event number
79292
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.